Given the current media attention and scrutiny regarding defective medical devices, including metal-on-metal hip replacements, and the recent landmark settlement involving a transvaginal mesh case, it is timely for pharmaceutical plaintiffs' lawyers to meet and discuss emerging trends in medical-related litigation. At the Plaintiff Forum on Pharmaceutical Litigation: Transvaginal Mesh, Actos and Orthopedic Devices in Philadelphia on Oct. 5, these topics and more will be examined in several in-depth sessions.
Motley Rice medical attorney Fred Thompson is the conference chair for transvaginal mesh. In addition to helping set the agenda, he will present on Best Practices for Navigating the Court Landscapes, including topics such as current litigation, trial preparation and related discovery issues.
Motley Rice medical attorney Fidelma Fitzpatrick will also present on Preparing Your Case: The FDA, Claims and Defenses. Discussions will include important considerations, documentation, choosing the best claims and parties to pursue, proving causation and more.
In June 2012, the FDA held a two-day advisory panel meeting to discuss how to monitor the more than half-million U.S. patients with metal hip replacements following the results of recent studies and the thousands of adverse reports the FDA has received in connection to the devices. Motley Rice is litigating cases involving recipients of potentially defective devices, including transvaginal mesh/sling products, hip replacements and defibrillator leads, who have suffered serious injuries.